Afferent Pharmaceuticals today announced that Michael M. Kitt, M.D., has been named to the newly created position of Chief Medical Officer, effective immediately. In addition, Afferent today announced the appointment of Kathleen Sereda Glaub to the Company’s Board of Directors, expanding the number of Company directors to six.
Help employers find you! Check out all the jobs and post your resume.
